NMPA Approval

Roxatidine Acetate Hydrochloride For Injection

Approval Number

国药准字H20249238

Company郑州维先医药科技有限公司

Registration Date

October 29, 2024

Drug Information

Generic Name

注射用盐酸罗沙替丁醋酸酯

Dosage Form

注射剂

Strength

75mg

Drug Type

化学药品

Registration Date

October 29, 2024

Company Information

Applicant Company

Company Name郑州维先医药科技有限公司

Company Address

河南省郑州市航空港经济综合实验区黄海路与生物科技二街交叉口郑州临空生物医药园1号楼6楼

Manufacturing Company

Company Name成都天台山制药股份有限公司

Company Address

四川省邛崃市天兴大道88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸罗沙替丁醋酸酯 - NMPA 批准文号 | MedPath